LMHRA Clarifies Media Reports of Counterfeit Medication
Terms oF Reference (ToR) for Expert Consultant to Develop the LMHRA Five-
Approved Premise Registration 2025 - 26.pdf
Approved Importers Listing 2025 - 26
ABRIDGED SDC FOR LMHRA_FINALMHRA
REVIEWED - LMHRA_SERVICE DELIVERY CHARTER_FINAL_V0.1
IFB for Computers & Accessories
IFB for Stationery
IFB for Prinitng & Binding
IFB for Office Machinery & Equipment
IFB for Medical Insurance
IFB for Laboratory Consumables
IFB for Furniture & Fixtures
Vehicle repairs & maintenance
IFBs for Vehicle Rental
LMHRA LAUNCHES SERVICE DELIVERY CHARTER TO ENHANCE REGULATORY SERVICES
LMHRA, NPHIL Participate in Global Fund Healthcare Waste Management Worksho
LMHRA MD Honored at Impact Africa Clinical Trials Summit
Join the Fight Against Antimicrobial Resistance
LMHRA, PEI Discuss Support for Pharmacovigilance & Clinical Trial
LMHRA Drafts Eight New Regulations
LMHRA Works Procurement, Invitation for Bids 2024
LMHRA Boss Envisions ISO-17025 Accreditation & WHO Maturity Level-3 In Two
PSA on LMHRA Confiscated Medicine
LMHRA DECLARES ‘FAILED PHARMACEUTICAL PRODUCT’, (PARA CLEAR PARACETAMOL